News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
335 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19556)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
Business
Intersect ENT Reports First Quarter 2018 Results
Intersect ENT, Inc. reported financial results for the first quarter ended March 31, 2018.
May 1, 2018
·
6 min read
Business
Gilead Sciences Announces Second Quarter 2018 Dividend
Gilead Sciences, Inc. announced that the company’s Board of Directors has declared a cash dividend of $0.57 per share of common stock for the second quarter of 2018.
May 1, 2018
·
1 min read
Genetown
Alnylam to Webcast Presentations at Several Upcoming May Investor Conferences
Alnylam Pharmaceuticals, Inc. announced that management will present company overviews at the following conferences:
May 1, 2018
·
1 min read
Business
Gilead Sciences Announces First Quarter 2018 Financial Results
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the first quarter ended March 31, 2018.
May 1, 2018
·
23 min read
Business
NeoImmuneTech Announces a Clinical Trial Collaboration with a Global Leading Pharmaceutical Company to Evaluate HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
NeoImmuneTech have entered into an agreement with Roche to enable studies of a combination treatment in three advanced high-risk skin cancer types.
May 1, 2018
·
4 min read
BioMidwest
IMRIS and Hill-Rom Announce Commercial Launch of New Magnetic Resonance Neurosurgical Table
IMRIS and Hill-Rom (NYSE: HRC) have commercially launched a new multi-functional operating room (OR) table specifically designed for the IMRIS Surgical Theatre.
May 1, 2018
·
4 min read
BioMidwest
Diplomat to Participate in 43rd Annual Deutsche Bank Health Care Conference
Diplomat Pharmacy, Inc. executives will attend the 43rd Annual Deutsche Bank Health Care Conference in Boston.
May 1, 2018
·
1 min read
Allergan to Present at the Deutsche Bank 43rd Annual Health Care Conference
Allergan plc announced that Chief Financial Officer Matthew Walsh will present at the Deutsche Bank 43rd Annual Health Care Conference in Boston, Massachusetts.
May 1, 2018
·
3 min read
Business
Revance Therapeutics Expands Leadership Team, Appointing Caryn McDowell as SVP, General Counsel & Corporate Secretary
Revance Therapeutics, Inc. announced the expansion of its executive leadership team with the appointment of Caryn McDowell as Senior Vice President, General Counsel, and Corporate Secretary, effective May 1, 2018.
May 1, 2018
·
4 min read
Business
Veracyte Announces First Quarter 2018 Financial Results
Veracyte, Inc. announced financial results for the first quarter ended March 31, 2018 and provided an update on recent business progress.
May 1, 2018
·
12 min read
Previous
30 of 34
Next